$2121 | SAVE $374 | Single User
$4242 | SAVE $748 | Site License
$6362 | SAVE $1,123 | Global License

COVID-19: Analysis of the Emerging Disease Landscape - March 2020

COVID-19: Analysis of the Emerging Disease Landscape - March 2020
[Lowest Price Guaranteed: $2,121]

Published by Global Data: 25 Mar 2020 | 253592 | In Stock
Related Topics: COVID

Introduction

COVID-19: Analysis of the Emerging Disease Landscape - March 2020

Summary

The epidemiology of COVID-19 is rapidly evolving and a number of companies have begun to invest in this space. The absence of proven therapeutic options and the lack of a vaccine to protect against infection has led to a race to develop effective interventions. A range of players - from pharma and biotech firms to academic institutions and government agencies - have thrown their hats in the ring.

Scope

- Global epidemiology metrics and trends

- Snapshot of epidemiological trends to date in the top three most-affected countries

- An overview of the pipeline for antivirals and vaccines

- Summary of available efficacy data

- An assessment of the clinical trials landscape by phase, sponsor type, geography, and other key attributes

- Highlights in deal-making trends, particularly public-private partnerships

- Spotlight on social media coverage

Reasons to Buy

- Global epidemiology metrics and trends

- Snapshot of epidemiological trends to date in the top three most-affected countries

- An overview of the pipeline for antivirals and vaccines

- Summary of available efficacy data

- An assessment of the clinical trials landscape by phase, sponsor type, geography, and other key attributes

- Highlights in deal-making trends, particularly public-private partnerships

- Spotlight on social media coverage

Table of Contents
for COVID-19: Analysis of the Emerging Disease Landscape - March 2020

  • Table of Contents

    1 Executive Summary

    1.1 Report Scope

    1.2 Navigate the COVID-19 Outbreak with GlobalData Pharma’s COVID-19 Dashboard

    1.3 Monitor the COVID-19 Outbreak with GlobalData Epidemiology Indicators

    2 Epidemiology

    2.1 Epidemiology: Snapshot as of March 25, 2020

    2.2 Epidemiology: Disease Trajectory as of March 25, 2020

    2.3 Epidemiology Indicators in the Top 3 Most-Affected Countries: Disease Trajectory in China as of March 25, 2020

    2.4 Epidemiology Indicators in the Top 3 Most-Affected Countries: Disease Trajectory in Italy as of March 25, 2020

    2.5 Epidemiology Indicators in the Top 3 Most-Affected Countries: Disease Trajectory in the US as of March 25, 2020

    2.6 Epidemiology Forecast: United States

    3 Pipeline Overview

    3.1 Pipeline Therapeutics: Breakdown by Phase

    3.2 Pipeline Therapeutics: Breakdown by Molecule Type

    3.3 Pipeline Therapeutics: Breakdown by Type of Developer

    3.4 Pipeline Therapeutics: Clinical-Stage Candidates (Phase I - III)

    3.5 Pipeline Therapeutics: Preclinical-Stage Candidates

    3.6 Pipeline Therapeutics: Currently Available Data

    3.7 Pipeline Vaccines: Breakdown by Phase

    3.8 Pipeline Vaccines: Breakdown by Developer Type

    3.9 Pipeline Vaccines: Clinical and Preclinical-Stage Candidates

    4 Pipeline Overview

    4.1 Pipeline Therapeutics: Breakdown by Phase

    4.2 Pipeline Therapeutics: Breakdown by Molecule Type

    4.3 Pipeline Therapeutics: Breakdown by Type of Developer

    4.4 Pipeline Therapeutics: Clinical-Stage Candidates (Phase I - III)

    4.5 Pipeline Therapeutics: Preclinical-Stage Candidates

    4.6 Pipeline Therapeutics: Currently Available Data

    4.7 Pipeline Vaccines: Breakdown by Phase

    4.8 Pipeline Vaccines: Breakdown by Developer Type

    4.9 Pipeline Vaccines: Clinical and Preclinical-Stage Candidates

    5 Clinical Trials

    5.1 Clinical Trials: Breakdown by Phase

    5.2 Clinical Trials for Therapeutics and Vaccines

    5.3 Clinical Trials: Overview by Region

    5.4 Clinical Trials for Therapeutics: Leading Sponsors

    5.5 Clinical Trials: Leading Industry Sponsors

    5.6 Trends in Trial Design

    6 Deal-making Trends

    6.1 Deal-making Trends

    7 Social Media Trends

    7.1 Key Twitter Chatter

    7.2 Top Trending Tweets include #Covid19 #Coronavirus #Patients #Flattenthecurve

    8 Key Findings

    8.1 Key Findings

    9 Appendix

    9.1 Sources

    9.2 Methodology

    9.3 About the Authors

    10 About GlobalData

    10.1 Contact Us

Additional Details

Publisher

Global Data

Publisher Information

Reference

253592 | GDHCHT052

Number of Pages

56

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! Insurance - Hong Kong: Coronavirus (COVID-19) Sector Impact
Insurance - Hong Kong: Coronavirus (COVID-19) Sector ImpactSummaryGlobalData’s 'Insurance - Hong Kon...
13 Apr 2020 by Global Data USD $1,696 (normally
USD $1,995)
More Info
SAVE 15% today! Commercial Aerospace - COVID-19 Sector Impact
Commercial Aerospace - COVID-19 Sector ImpactSummaryThe Commercial Aerospace sector is almost entire...
10 Apr 2020 by Global Data USD $421 (normally
USD $495)
More Info
SAVE 15% today! Insurance - UK: Coronavirus (COVID-19) Sector Impact
Insurance - UK: Coronavirus (COVID-19) Sector ImpactSummaryGlobalData’s 'Insurance - UK: Coronavirus...
09 Apr 2020 by Global Data USD $1,696 (normally
USD $1,995)
More Info
SAVE 15% today! Insurance - Taiwan: Coronavirus (COVID-19) Sector Impact
Insurance - Taiwan: Coronavirus (COVID-19) Sector ImpactSummaryGlobalData’s 'Insurance - Taiwan: Cor...
08 Apr 2020 by Global Data USD $1,696 (normally
USD $1,995)
More Info
SAVE 15% today! Insurance - Italy: Coronavirus (COVID-19) Sector Impact
Insurance - Italy: Coronavirus (COVID-19) Sector ImpactSummaryGlobalData’s 'Insurance - Italy: Coron...
08 Apr 2020 by Global Data USD $1,696 (normally
USD $1,995)
More Info
SAVE 15% today! Insurance - India: Coronavirus (COVID-19) Sector Impact
Insurance - India: Coronavirus (COVID-19) Sector ImpactSummaryGlobalData’s 'Insurance - India: Coron...
07 Apr 2020 by Global Data USD $1,696 (normally
USD $1,995)
More Info
SAVE 15% today! Insurance - Japan: Coronavirus (COVID-19) Sector Impact
Insurance - Japan: Coronavirus (COVID-19) Sector ImpactSummaryGlobalData’s 'Insurance - Japan: Coron...
07 Apr 2020 by Global Data USD $1,696 (normally
USD $1,995)
More Info
SAVE 15% today! Insurance - Australia: Coronavirus (COVID-19) Sector Impact
Insurance - Australia: Coronavirus (COVID-19) Sector ImpactSummaryGlobalData’s 'Insurance - Australi...
07 Apr 2020 by Global Data USD $1,696 (normally
USD $1,995)
More Info
SAVE 15% today! Insurance - France: Coronavirus (COVID-19) Sector Impact
Insurance - France: Coronavirus (COVID-19) Sector ImpactSummaryGlobalData’s 'Insurance - France: Cor...
07 Apr 2020 by Global Data USD $1,696 (normally
USD $1,995)
More Info
SAVE 15% today! Coronavirus Disease (COVID-19): Epidemiology Analysis and Forecast - March 2020
Coronavirus Disease (COVID-19): Epidemiology Analysis and Forecast - March 2020SummaryThe report cov...
31 Mar 2020 by Global Data USD $1,696 (normally
USD $1,995)
More Info

This report is published by Global Data

Download Free Report Summary PDF

COVID-19: Analysis of the Emerging Disease Landscape - March 2020 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...